Publications of Hermina Robotka
All genres
Journal Article (21)
2023
Journal Article
42 (2), 112034 (2023)
Sparse ensemble neural code for a complete vocal repertoire. Cell Reports 2022
Journal Article
13 (4), pp. 813 - 825 (2022)
Ecological inference using data from accelerometers needs careful protocols. Methods in Ecology and Evolution
Journal Article
19 (193), 20220168 (2022)
The role of wingbeat frequency and amplitude in flight power. Interface: Journal of the Royal Society
Journal Article
25 (9), 104878 (2022)
Wake respirometry allows breath-by-breath assessment of ventilation and CO2 production in unrestrained animals. iScience 2020
Journal Article
89 (1), pp. 161 - 172 (2020)
Estimates for energy expenditure in free-living animals using acceleration proxies: A reappraisal. Journal of Animal Ecology 2016
Journal Article
8 (Suppl. 2), pp. 23 - 28 (2016)
Hepatoprotective liposomal glycyrrhizin in alcoholic liver injury. European Journal of Integrative Medicine 2015
Journal Article
10, 39 (2015)
Draft genome sequence of Methylibium sp. strain T29, a novel fuel oxygenate-degrading bacterial isolate from Hungary. Standards in Genomic Sciences 2012
Journal Article
165 (4), pp. 482 - 487 (2012)
Flow cytometric analysis of supravesicular structures in doxorubicin-containing pegylated liposomes. Chemistry and Physics of Lipids 2010
Journal Article
117 (2), pp. 183 - 188 (2010)
A novel kynurenic acid analogue: A comparison with kynurenic acid. An in vitro electrophysiological study. Journal of Neural Transmission 2008
Journal Article
61 (4), pp. 429 - 432 (2008)
The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: Comparative studies of the effects of SZR-72 and kynurenic acid. Neuroscience Research
Journal Article
82 (17-18), pp. 915 - 919 (2008)
Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate. Life Sciences
Journal Article
3 (2), pp. 169 - 188 (2008)
L-kynurenine: Metabolism and mechanism of neuroprotection. Future Neurology
Journal Article
76 (5), pp. 474 - 479 (2008)
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: An in vitro study. Brain Research Bulletin
Journal Article
115 (8), pp. 1087 - 1091 (2008)
The Janus-face kynurenic acid. Journal of Neural Transmission
Journal Article
32 (2), pp. 302 - 308 (2008)
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus. Neurobiology of Disease 2007
Journal Article
7, pp. 45 - 56 (2007)
Kynurenines in the central nervous system: Recent developments. Central Nervous System Agents in Medical Chemistry
Journal Article
257 (1-2), pp. 221 - 239 (2007)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Journal of the Neurological Sciences 2006
Journal Article
156 (1-2), pp. 231 - 235 (2006)
Hippocampal (CA1) activities in Wistar rats from different vendors: Fundamental differences in acute ischemia. Journal of Neuroscience Methods 2005
Journal Article
513 (1-2), pp. 75 - 80 (2005)
Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus. European Journal of Pharmacology
Journal Article
18 (3), pp. 499 - 508 (2005)
Pentapeptides derived from Aβ1–42 protect neurons from the modulatory effect of Aβ fibrils: An in vitro and in vivo electrophysiological study. Neurobiology of Disease 2004
Journal Article
47, pp. 916 - 925 (2004)
Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study. Neuropharmacology